Skip to content

Day 3 Parallel Sessions

Friday, April 5, 2024 

Session Time TitleOrganizers
S4A10:15-11:30am Causal Inference Methods to Estimate Treatment Effects in Clinical TrialsSudhakar Rao (Janssen)
Xiang Li (Johnson & Johnson)
S4B10:15-11:30am Statistical Innovation in the Application of ctDNA in Oncology Drug DevelopmentShibing Deng (Pfizer)
S4C10:15-11:30am Bridging Early Insights for Enhanced Oncology Decision-MakingMiaomiao Ge (BI)
Wenqiong Xue (BI)
S5A11:45-1:00pmHonoring Professor Shein-Chung Chow’s 40 years of Contributions to Statistical and Regulatory SciencesMark Chang (Boston University)
Herbert Pang (Genentech)
Xiaofei Wang (Duke)
S6A1:00-3:00pm Advancing Dose Optimization: Innovations and PracticesYing Yuan (University of Texas MD Anderson Cancer Center)
S6B1:00-3:00pm Statistical Significance, Clinical Meaningfulness, and Regulatory Consideration for Rare Disease Drugs’ Approval – Examples SharingYeh-Fong Chen (FDA) Huan Wang (FDA/CDER)
S6C1:00-3:00pm Statistical Innovation in Biosimilar and Bioequivalence StudiesFairouz Makhlouf (FDA)
Shein-Chung Chow (Duke)